Harte Hanks Stock Price, News & Analysis

Harte Hanks (Nasdaq: HHS) will release its financial results for Q1 2022 on May 12, 2022, following market close. A conference call is scheduled for the same day at 4:30 p.m. ET to discuss the results. The event will be accessible via webcast and telephone for interested parties. The company specializes in customer experience solutions, providing analytics and insights to help clients engage better with customers. Harte Hanks has a solid client base, including major brands such as Ford and Pfizer.

Harte Hanks (Nasdaq: HHS) has secured a contract with a multinational technology firm to enhance its B2B marketing through an omnichannel program. This agreement will leverage Harte Hanks' extensive experience in managing partner reseller initiatives, program strategy, media buying, and data analytics. CEO Brian Linscott emphasizes the focus on investing in technology and talent to foster growth for clients while optimizing their resources. The company boasts a long-term track record in delivering customer experience solutions across global markets.

Harte Hanks (Nasdaq: HHS) has announced its participation in the Noble Capital Markets' 18th Annual Investor Conference (NobleCon18) scheduled for April 20, 2022. The presentation will occur at 9:30 a.m. ET, at the Hard Rock Hotel & Casino in Hollywood, Florida. CEO Brian Linscott and CFO Lauri Kearnes will lead the discussion, with breakout sessions at 1:45 p.m. ET and 3:15 p.m. ET. Interested participants can register via Noble Capital Markets' website. A video webcast will be available the following day on Harte Hanks' investor relations site.

Harte Hanks (Nasdaq: HHS) partnered with a leading global financial services corporation to deliver over 300,000 at-home Covid-19 testing kits during the Omicron surge. Additionally, the company distributed more than 60,000 wellness kits containing hand sanitizers and PPE masks to its employees. This initiative was supported by their FDA-certified distribution center in Kansas City, allowing prompt delivery. The company emphasizes its significant investments in fulfillment facilities as a driver of growth amidst ongoing supply chain challenges.

Harte Hanks (HHS) reported a 10% revenue increase in Q4 2021, totaling $52.0 million, up from $47.1 million in Q4 2020. Diluted EPS rose to $0.20 from $0.11. Full-year revenues also improved by 10% to $194.6 million, while net income surged to $15.0 million compared to a net loss of $1.7 million in 2020. The company achieved an operating income of $7.6 million, reversing a previous loss. Cash and equivalents decreased to $15.1 million, but the company expects a $7.8 million tax refund to boost liquidity. CEO Brian Linscott emphasized sustainable profitability growth in 2022.

Harte Hanks, Inc. (Nasdaq: HHS) announced it will release its financial results for Q4 ended December 31, 2021, after the market closes on February 24, 2022. A conference call will follow at 4:30 p.m. ET to discuss the results. Interested parties can access the webcast online or via phone. The company specializes in customer experience strategies and analytics, serving clients like Bank of America and Pfizer, with over 2,500 employees in multiple regions.

Harte Hanks (Nasdaq: HHS) has secured a multi-year contract from a national healthcare organization to provide new mothers with essential products, including breast milk pumps and health-related materials. This initiative aligns with the Affordable Care Act's goal to enhance newborn nutrition. Over 100,000 breast milk kits are expected to be delivered in the first year. Harte Hanks was chosen for its comprehensive, cost-effective solutions and established relationship with the client, enabling efficient service delivery.

Harte Hanks (Nasdaq: HHS) announced the launch of an expanded healthcare practice, spearheaded by Janel Harris, an executive with extensive healthcare agency experience. The practice aims to leverage integrated services including patient insights and data analytics, enhancing client engagement in the healthcare sector. The company operates multiple distribution centers, including a new 400,000 square foot facility in Kansas City, fulfilling over 1.3 million packages annually. Harte Hanks continues to cater to major clients like GSK and Pfizer, aiming to provide comprehensive patient-centric solutions.

Harte Hanks (Nasdaq: HHS), a global customer experience company, will present at the Sidoti & Company Virtual Small-Cap Conference on January 20, 2022, at 10 a.m. ET. Management will also hold one-on-one meetings on January 19 and 20, 2022. Interested parties can access the presentation via webcast on the Harte Hanks investor relations website. For meeting requests, participants may contact their Sidoti representative or email hhs@fnkir.com.